Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
about
Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesProminent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome.Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes.Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy.Comèl-Netherton syndrome defined as primary immunodeficiency.Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept StudyProteomics: applications in transfusion medicine.Outcome of Intravenous Immunoglobulin-Transmitted HTLV-I, Hepatitis B, Hepatitis C, and HIV infections.Intravenous immunoglobulins--understanding properties and mechanisms.Review of intravenous immunoglobulin in the treatment of stevens-johnson syndrome and toxic epidermal necrolysis.Stevens-Johnson syndrome after Mycoplasma pneumonia infection in pediatric post-liver transplant recipient: case report and review of the literature.Clinical use of polyvalent immunoglobulinsClinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies.A new support material for IgG adsorption: Syntrichia papillosissima (Copp.) Loeske.Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus.Recommendations for the use of albumin and immunoglobulins.Hyperimmune globulins and same-day thrombotic adverse events as recorded in a large healthcare database during 2008-2011.Antibody separation using lectin modified poly(HEMA-EDMA) hydrogel membranes.
P2860
Q28069362-501A39E3-E1CD-4DC7-9B0F-43ED594FB26BQ33332176-80B1C3D2-5557-49FF-BA2E-C75CC28BAA1CQ33408909-2EFC95C3-0A68-4D23-9445-B651DF637872Q33723798-535A9FE5-9D88-428F-821B-1831BCC43B31Q34997608-0E1A4472-FCE3-43F4-B747-134BFB5DF53BQ35289684-2D651A49-4503-4D74-BCA9-37A1DF103619Q37062388-4D298997-A92E-4C56-BA90-EECF61D631F8Q37435375-940EE6E9-FEB6-4DFE-9F49-E66FE86A3E87Q37626118-68F6104F-2459-41D8-A3C8-DBD791EC61E7Q37802203-A539D857-864F-4A31-A21A-1862C1E119C6Q37822905-0A2A48E0-DC6D-45D6-AAC1-8B0FD9DCB34FQ38170872-DA5B8742-C7B2-499E-AC37-6676D31AC607Q38281407-580513B9-5A1E-4A2B-A7DD-FE8ACF6428CBQ38921610-D5C6B8CC-AEBE-4BF0-9D26-C0F90CB994B6Q39207717-C04D013D-E9E0-46A2-A190-A5546290B6C3Q42671923-FF2D37FB-FA5B-48E1-8075-34C39A2D4BC0Q46267598-5FA43629-0DAA-47ED-AEF3-7DBECFF38290Q51753536-8D95C7CA-F7E4-4F8E-AFFD-4CD16FD75D39
P2860
Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Efficacy of various intravenou ...... hronic inflammatory disorders.
@ast
Efficacy of various intravenou ...... hronic inflammatory disorders.
@en
type
label
Efficacy of various intravenou ...... hronic inflammatory disorders.
@ast
Efficacy of various intravenou ...... hronic inflammatory disorders.
@en
prefLabel
Efficacy of various intravenou ...... hronic inflammatory disorders.
@ast
Efficacy of various intravenou ...... hronic inflammatory disorders.
@en
P2860
P356
P1476
Efficacy of various intravenou ...... hronic inflammatory disorders.
@en
P2093
A Razzaque Ahmed
Hakan M Gürcan
P2860
P304
P356
10.1345/APH.1K037
P407
P577
2007-04-17T00:00:00Z